Status: Recruiting
The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy
This prospective multicentric academic NAPT study aims to compile a database of all patients who initiate immunotherapy. The NAPT will take place before, during and after AIT to evaluate the cost and effectiveness of the treatment. The study consists of 4 visits and 2 telephone contacts that are repeated annually for 3 years. This study will be conducted in 2 hospitals: UZ Leuven and AZ ST. Jan Brugge on the consultation Ear, Nose and Throat Diseases (ENT) and the department of Internal Medicine / Allergology
Participants needed: 200
Trial details
Age: 18-60Biological sex: AllType: ObservationalSponsor: Universitaire Ziekenhuizen KU LeuvenUpdated: May 1, 2026Locations: 2Duration: 3 Years
Eligibility criteria
Age >18 and ≤60 years [+4]
Uncontrolled asthma [+7]